Literature DB >> 15622569

Outcome of local excision of rectal carcinoma.

D Gopaul1, P Belliveau, T Vuong, J Trudel, C A Vasilevsky, R Corns, Philip H Gordon.   

Abstract

PURPOSE: This study was designed to determine the results of patients with rectal adenocarcinoma treated with local excision.
METHODS: A retrospective, chart review was conducted for all patients treated with local excision for rectal adenocarcinoma from 1984 to 1998.
RESULTS: Sixty-four patients were retained for analysis. The median follow-up was 37 (range, 9-125) months. There were 15 local failures with a median time to local failure of 12 months. Seven patients were salvaged with further operation (4 by repeat local excision, 4 by abdominoperineal resection, and 1 by low anterior resection). The incidence of local recurrence increased with advancing stage of the carcinoma (T1, 13 percent; T2, 24 percent; T3, 71 percent), histologic grade of differentiation, (well, 12 percent; moderately, 24 percent; poorly, 44 percent), and margin status (negative, 16 percent; close (within 2 mm), 33 percent; positive, 50 percent). Sixteen percent of carcinomas < or = 3 cm failed compared with 47 percent for carcinomas > 3 cm. Nine percent (1/11) of T2 patients treated with adjuvant radiation therapy recurred locally compared with 36 percent (5/14) without radiation therapy. Three of four T3 patients who received radiation therapy failed locally compared with two of three who did not. Using the Kaplan-Meier method, the overall survival at five years was 71 percent, and disease-free survival was 83 percent. Actuarial local failure was 27 percent and freedom from distant metastasis was 86 percent. The sphincter preservation rate was 90 percent at five years.
CONCLUSIONS: Local excision alone is an acceptable option for well-differentiated, T1 carcinomas, < or = 3 cm. Adjuvant radiation is recommended for T2 lesions. The high local recurrence rate in patients after local excision of T3 lesions with or without adjuvant radiotherapy would mandate a radical resection.

Entities:  

Mesh:

Year:  2004        PMID: 15622569     DOI: 10.1007/s10350-004-0678-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

1.  Oncological outcomes of transanal local excision for high risk T(1) rectal cancers.

Authors:  Ze-Yu Wu; Gang Zhao; Zhe Chen; Jia-Lin Du; Jin Wan; Feng Lin; Lin Peng
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

2.  Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision.

Authors:  Emanuele Lezoche; Alessandro M Paganini; Bernardina Fabiani; Andrea Balla; Annarita Vestri; Lorenzo Pescatori; Daniele Scoglio; Giancarlo D'Ambrosio; Giovanni Lezoche
Journal:  Surg Endosc       Date:  2013-09-04       Impact factor: 4.584

3.  Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis.

Authors:  Lawrence Lee; Justin Kelly; George J Nassif; Sam B Atallah; Matthew R Albert; Ravi Shridhar; John R T Monson
Journal:  J Gastrointest Surg       Date:  2017-08-17       Impact factor: 3.452

Review 4.  A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors.

Authors:  Thomas A Heafner; Sean C Glasgow
Journal:  J Gastrointest Oncol       Date:  2014-10

Review 5.  Toward the non-surgical management of locally advanced rectal cancer.

Authors:  Alice Dewdney; David Cunningham
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

6.  Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.

Authors:  Oliver K Jawitz; Mohamed A Adam; Megan C Turner; Brian F Gilmore; John Migaly
Journal:  Surgery       Date:  2019-03-21       Impact factor: 3.982

Review 7.  Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.

Authors:  Sean C Glasgow; Joshua I S Bleier; Lawrence J Burgart; Charles O Finne; Ann C Lowry
Journal:  J Gastrointest Surg       Date:  2012-01-19       Impact factor: 3.452

8.  Endoscopic posterior mesorectal resection as an option to combine local treatment of early stage rectal cancer with partial mesorectal lymphadenectomy.

Authors:  Jörg Köninger; Beat P Müller-Stich; Frank Autschbach; Peter Kienle; Jürgen Weitz; Markus W Büchler; Carsten N Gutt
Journal:  Langenbecks Arch Surg       Date:  2007-07-18       Impact factor: 3.445

9.  Is Previous Transanal Endoscopic Microsurgery for Early Rectal Cancer a Risk Factor of Worse Outcome following Salvage Surgery A Case-Matched Analysis.

Authors:  Audrius Dulskas; Aivaras Atkociunas; Alfredas Kilius; Kestutis Petrulis; Narimantas E Samalavicius
Journal:  Visc Med       Date:  2018-12-15

10.  Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference.

Authors:  Mario Morino; Mauro Risio; Simon Bach; Regina Beets-Tan; Krzysztof Bujko; Yves Panis; Philip Quirke; Bjorn Rembacken; Eric Rullier; Yutaka Saito; Tonia Young-Fadok; Marco Ettore Allaix
Journal:  Surg Endosc       Date:  2015-01-22       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.